Elez, E., Pericay, C., Valladares-Ayerbes, M., Bando, I., Safont, M. J., Gallego, J., . . . Aranda, E. (2019). A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients.
Citação norma ChicagoElez, Elena, et al. A Phase 2 Study of Panitumumab With Irinotecan As Salvage Therapy in Chemorefractory KRAS Exon 2 Wild-type Metastatic Colorectal Cancer Patients. 2019.
Citação norma MLAElez, Elena, et al. A Phase 2 Study of Panitumumab With Irinotecan As Salvage Therapy in Chemorefractory KRAS Exon 2 Wild-type Metastatic Colorectal Cancer Patients. 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.